Evidence map›Paper›PMID 31886938›Full record

ArticleJournal of cellular and molecular medicine2020

Divergent effects of canonical and non-canonical TGF-β signalling on mixed contractile-synthetic smooth muscle cell phenotype in human Marfan syndrome aortic root aneurysms.

Albert J Pedroza, Tiffany Koyano, Jeffrey Trojan, Adam Rubin, Itai Palmon, Kevin Jaatinen, Grayson Burdon, Paul Chang, Yasushi Tashima, Jason Z Cui and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Albert J PedrozaDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.ORCID 0000-0001-5291-5980
Tiffany KoyanoDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
Jeffrey TrojanDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
Adam RubinStanford University School of Medicine, Stanford, California.
Itai PalmonDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
Kevin JaatinenDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
Grayson BurdonDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
Paul ChangDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
Yasushi TashimaDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
Jason Z CuiDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
Gerry BerryDepartment of Pathology, Stanford University School of Medicine, Stanford, California.
Cristiana IosefDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.ORCID 0000-0002-0535-8605
Michael P FischbeinDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.ORCID 0000-0002-0638-2025
Stanford University · US

Funding

Marfan Aortic Embryologic Origin Influences miR-29b Regulators and TargetsR01AR066629 · NIAMS · STANFORD UNIVERSITY · PI FISCHBEIN, MICHAEL PETER · 2016 to 2020
$1.5M
NIAMS NIH HHS R01 AR066629
6 · The paper itself

Abstract

Aortic root aneurysm formation is a cardinal feature of Marfan syndrome (MFS) and likely TGF-β driven via Smad (canonical) and ERK (non-canonical) signalling. The current study assesses human MFS vascular smooth muscle cell (SMC) phenotype, focusing on individual contributions by Smad and ERK, with Notch3 signalling identified as a novel compensatory mechanism against TGF-β-driven pathology. Although significant ERK activation and mixed contractile gene expression patterns were observed by traditional analysis, this did not directly correlate with the anatomic site of the aneurysm. Smooth muscle cell phenotypic changes were TGF-β-dependent and opposed by ERK in vitro, implicating the canonical Smad pathway. Bulk SMC RNA sequencing after ERK inhibition showed that ERK modulates cell proliferation, apoptosis, inflammation, and Notch signalling via Notch3 in MFS. Reversing Notch3 overexpression with siRNA demonstrated that Notch3 promotes several protective remodelling pathways, including increased SMC proliferation, decreased apoptosis and reduced matrix metalloproteinase activity, in vitro. In conclusion, in human MFS aortic SMCs: (a) ERK activation is enhanced but not specific to the site of aneurysm formation; (b) ERK opposes TGF-β-dependent negative effects on SMC phenotype; (c) multiple distinct SMC subtypes contribute to a 'mixed' contractile-synthetic phenotype in MFS aortic aneurysm; and (d) ERK drives Notch3 overexpression, a potential pathway for tissue remodelling in response to aneurysm formation.

Indexed as

AortaAortic AneurysmApoptosisCell LineCell ProliferationHumansInflammationMarfan SyndromeMuscle ContractionMuscle, Smooth, VascularMyocytes, Smooth MusclePhenotypeReceptor, Notch3Signal TransductionTransforming Growth Factor betaReceptor, Notch3Transforming Growth Factor betaaortic aneurysmMarfan syndromesmooth muscle cell phenotype

Identifiers

PMID31886938
PMCPMC7011150
OpenAlexW2997852414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.